Spironolactone
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00421 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 10 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hypotrichosis simplex of the scalp | KG + DL |
| 2 | congenital hypotrichosis milia | KG + DL |
| 3 | diffuse alopecia areata | KG + DL |
| 4 | alopecia | KG + DL |
| 5 | malignant hypertensive renal disease | KG + DL |
| 6 | malignant renovascular hypertension | KG + DL |
| 7 | pulmonary hypertension with unclear multifactorial mechanism | KG + DL |
| 8 | pulmonary hypertension owing to lung disease and/or hypoxia | KG + DL |
| 9 | Braddock syndrome | KG + DL |
| 10 | chronic pulmonary heart disease | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.